CHAD HILLYER: Open Payments
NPI 1902825904 · ELKHORN, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,842 in 151 payments from 19 companies in 2025. Trend: 2023 $3,453 · 2024 $3,426 · 2025 $2,842
Food & beverage: $2,773Education: $69
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 26 | $454 |
| GENZYME CORPORATION | 13 | $389 |
| E.R. Squibb & Sons, L.L.C. | 21 | $287 |
| LEO Pharma Inc. | 8 | $248 |
| Novartis Pharmaceuticals Corporation | 11 | $241 |
| Regeneron Healthcare Solutions, Inc. | 8 | $208 |
| MAYNE PHARMA COMMERCIAL LLC | 13 | $176 |
| Lilly USA, LLC | 12 | $175 |
| Janssen Biotech, Inc. | 9 | $154 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 9 | $148 |
Products named: DUPIXENT, Sotyktu, SKYRIZI, RINVOQ, COSENTYX, ANZUPGO, TREMFYA, ILUMYA.
Industry payments across NE — which companies pay providers there.
